Dr. Sarder demonstrates AI-Driven Breakthrough in Kidney Transplant Biopsy Assessment at SSKWS
Dr. Sarder presented to attendees at SSKWS that quantitative renal biopsy assessments for transplantation, when enhanced by AI-powered computational pathomic analysis, are expected to significantly outperform stand-alone assessments by on-call pathologists in terms of accuracy. He explained that this advancement will not only reduce organ discard rates but also improve organ quality estimation. Furthermore, Dr. Sarder presented that it would be a critical step toward better donor-recipient matching, ultimately leading to enhanced graft allocation and improved long-term outcomes for transplant patients.